Categories Earnings, Technology

Okta’s shares gain after Q1 results surpass expectations

Okta Inc. (NASDAQ: OKTA) topped market expectations on revenue and reported a narrower-than-expected loss for the first quarter of 2020, allowing shares to gain over 4% in premarket hours on Thursday.

Total revenue grew 50% year-over-year to $125.2 million, beating estimates of $116 million. Subscription revenue rose 52% to $117.2 million.

GAAP net loss was $52 million, or $0.46 per share, compared to $26 million, or $0.25 per share, in the year-ago quarter. Adjusted net loss was $21.4 million, or $0.19 per share. The target for adjusted EPS was $0.21.

During the quarter, Okta saw a 53% year-over-year growth in customers with over $100,000 in annual contract value.

Todd McKinnon, CEO and co-founder of Okta said, “Last month at Oktane19, we announced new products that further advance our leadership in both workforce and customer identity. These new innovations, coupled with our existing best-in-class offerings, position us well to continue executing on our significant and growing market opportunities.”

For the second quarter of 2020, total revenue is expected to grow 37-38% year-over-year to $130 million to $131 million. Adjusted loss per share is expected to be $0.11 to $0.10.

For full-year 2020, revenue is targeted to be $543 million to $548 million, representing a year-over-year growth rate of 36-37%, while adjusted loss per share is projected to be $0.49 to $0.45.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top